{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:56:57Z","timestamp":1776488217103,"version":"3.51.2"},"reference-count":40,"publisher":"Nihon University School of Dentistry","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Oral Sci","Journal of Oral Science"],"published-print":{"date-parts":[[2026]]},"DOI":"10.2334\/josnusd.25-0294","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T22:09:40Z","timestamp":1771970980000},"page":"59-65","source":"Crossref","is-referenced-by-count":0,"title":["Stage-specific analysis of targeted microRNAs in oral squamous cell carcinoma and their association with the use of naswar"],"prefix":"10.2334","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2721-4776","authenticated-orcid":false,"given":"Nasiha","family":"Bashir","sequence":"first","affiliation":[{"name":"Department of Oral Pathology, Faculty of Health and Medical Sciences, Riphah International University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2765-3617","authenticated-orcid":false,"given":"Sajjad","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology, Faculty of Health and Medical Sciences, Riphah International University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2181-4156","authenticated-orcid":false,"given":"Fatima","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology, Faculty of Health and Medical Sciences, Riphah International University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2743-8677","authenticated-orcid":false,"given":"Laiba","family":"Fayyaz","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology, Faculty of Health and Medical Sciences, Riphah International University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0711-6167","authenticated-orcid":false,"given":"Tehmina","family":"Naushin","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology, Faculty of Health and Medical Sciences, Riphah International University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1160","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Rajan C, Roshan VGD, Khan I, Manasa VG, Himal I, Kattoor J et al. (2021) MiRNA expression profiling and emergence of a new prognostic signature for oral squamous cell carcinoma. Sci Rep 11, 7298. doi:10.1038\/s41598-021-86316-w","DOI":"10.1038\/s41598-021-86316-w"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al. (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74, 229-263. doi:10.3322\/caac.21834","DOI":"10.3322\/caac.21834"},{"key":"3","unstructured":"3. Yoon AJ, Wang S, Shen J, Robine N, Philipone E, Oster MW et al. (2014) Prognostic value of miR-375 and miR-214-3p in early-stage oral squamous cell carcinoma. Am J Transl Res 6, 580-590."},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Iqbal F, Ahmad S, Maryam H, Amin H (2025) Evidence of mutations in tumour suppressor genes among oral cancer in Naswar, smokeless tobacco users. Acta Odontol Scand 84, 43778. doi:10.2340\/aos.v84.43778","DOI":"10.2340\/aos.v84.43778"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Arslan Bozdag L, A\u00e7ik L, Ersoy HE, Bayir \u00d6, Korkmaz MH, Mollaoglu N et al. (2024) PDCD4 and miR-21 are promising biomarkers in the follow-up of OED in liquid biopsies. Oral Dis 30, 3873-3883. doi:10.1111\/odi.14817","DOI":"10.1111\/odi.14817"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gissi DB, Morandi L, Gabusi A, Tarsitano A, Marchetti C, Cura F et al. (2018) A noninvasive test for microRNA expression in oral squamous cell carcinoma. Int J Mol Sci 19, 1789. doi:10.3390\/ijms19061789","DOI":"10.3390\/ijms19061789"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Salazar-Ruales C, Arguello JV, L\u00f3pez-Cort\u00e9s A, Cabrera-Andrade A, Garc\u00eda-C\u00e1rdenas JM, Guevara-Ram\u00edrez P et al. (2018) Salivary microRNAs for early detection of head and neck squamous cell carcinoma: a case-control study in the high altitude mestizo Ecuadorian population. Biomed Res Int 2018, 9792730. doi:10.1155\/2018\/9792730","DOI":"10.1155\/2018\/9792730"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Bautista-S\u00e1nchez D, Arriaga-Canon C, Pedroza-Torres A, De La Rosa-Vel\u00e1zquez IA, Gonz\u00e1lez-Barrios R, Contreras-Espinosa L et al. (2020) The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics. Mol Ther Nucleic Acids 20, 409-420. doi:10.1016\/j.omtn.2020.03.003","DOI":"10.1016\/j.omtn.2020.03.003"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Wei J, Lu Y, Wang R, Xu X, Liu Q, He S et al. (2021) MicroRNA-375: potential cancer suppressor and therapeutic drug. Biosci Rep 41, BSR20211494. doi:10.1042\/BSR20211494","DOI":"10.1042\/BSR20211494"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Prasad M, Hamsa D, Fareed M, Karobari MI (2025) An update on the molecular mechanisms underlying the progression of miR-21 in oral cancer. World J Surg Oncol 23, 73. doi:10.1186\/s12957-025-03732-2","DOI":"10.1186\/s12957-025-03732-2"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Hema Shree K, Ramani P, Sherlin H, Sukumaran G, Jeyaraj G, Don K et al. (2019) Saliva as a diagnostic tool in oral squamous cell carcinoma \u2013 a systematic review with meta-analysis. Pathol Oncol Res 25, 447-453. doi:10.1007\/s12253-019-00588-2","DOI":"10.1007\/s12253-019-00588-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Siddiqui MF, Raees U, Hassan B (2021) Squamous cell carcinoma and its association to different chewing habits in Punjab, Pakistan. Diet Factor 2, 24-28. doi:10.54393\/df.v2i02.36","DOI":"10.54393\/df.v2i2.36"},{"key":"13","unstructured":"13. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization (2007) Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum 89, 1-635."},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Lin X, Wu W, Ying Y, Luo J, Xu X, Zheng L et al. (2022) MicroRNA-31: a pivotal oncogenic factor in oral squamous cell carcinoma. Cell Death Discov 8, 140. doi:10.1038\/s41420-022-00948-z","DOI":"10.1038\/s41420-022-00948-z"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yoshizawa JM, Wong DT (2013) Salivary microRNAs and oral cancer detection. Methods Mol Biol 936, 313-324. doi:10.1007\/978-1-62703-083-0_24","DOI":"10.1007\/978-1-62703-083-0_24"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25, 402-408. doi:10.1006\/meth.2001.1262","DOI":"10.1006\/meth.2001.1262"},{"key":"17","unstructured":"17. Gombos K, Horv\u00e1th R, Szele E, Juh\u00e1sz K, G\u0151cze K, Somlai K et al. (2013) miRNA expression profiles of oral squamous cell carcinomas. Anticancer Res 33, 1511-1517."},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Reddy CSS, PP ASU, Ganapathy DM, Ameya K, Sekar D (2024) MicroRNA-21 as a biomarker in terminal stage oral squamous cell carcinoma (OSCC) in the South Indian population. Oral Oncol Rep 9, 100139. doi:10.1016\/j.oor.2024.100609","DOI":"10.1016\/j.oor.2024.100609"},{"key":"19","unstructured":"19. Singh P, Srivastava AN, Sharma R, Mateen S, Shukla B, Singh A et al. (2018) Circulating microRNA-21 expression as a novel serum biomarker for oral submucous fibrosis and oral squamous cell carcinoma. Asian Pac J Cancer Prev 19, 1053-1057. doi:10.22034\/APJCP.2018.19.4.1053"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Narasimhan NS, Narasimhan NM (2018) The emerging role of microRNA-21 in oral cancer. Biomed Pharmacol J 11, 1961-1966. doi:10.13005\/bpj\/1569","DOI":"10.13005\/bpj\/1569"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Tseng H-H, Tseng Y-K, You J-J, Kang B-H, Wang T-H, Yang C-M et al. (2017) Next-generation sequencing for microRNA profiling: microRNA-21-3p promotes oral cancer metastasis. Anticancer Res, 37, 1059-1066. doi: 10.21873\/anticanres.11417","DOI":"10.21873\/anticanres.11417"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Yu T, Ma P, Wu D, Shu Y, Gao W (2018) Functions and mechanisms of microRNA-31 in human cancers. Biomed Pharmacother 108, 1162-1169. doi:10.1016\/j.biopha.2018.09.132","DOI":"10.1016\/j.biopha.2018.09.132"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Siow M, Ng KL, Chong VV, Jamaludin M, Abraham MT, Abdul Rahman Z et al. (2014) Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma. Oral Dis 20, 345-351. doi:10.1111\/odi.12118","DOI":"10.1111\/odi.12118"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Kumari P, Syed SA, Wahid M, Qureshi MA, Kumar R (2021) Expression of miR-31 in saliva-liquid biopsy in patients with oral squamous cell carcinoma. J Taibah Univ Med Sci 16, 733-739. doi:10.1016\/j.jtumed.2021.03.007","DOI":"10.1016\/j.jtumed.2021.03.007"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Iacona JR, Lutz CS (2019) miR-146a-5p: expression, regulation, and functions in cancer. Wiley Interdiscip Rev RNA 10, e1533. doi:10.1002\/wrna.1533","DOI":"10.1002\/wrna.1533"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Shahriar A, Shiva GG, Ghader B, Farhad J, Hosein A, Parsa H (2020) The dual role of miR-146a in metastasis and disease progression. Biomed Pharmacother 126, 110099. doi:10.1016\/j.biopha.2020.110099","DOI":"10.1016\/j.biopha.2020.110099"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Shi Z, Johnson JJ, Jiang R, Liu Y, Stack MS (2015) Decrease of miR-146a is associated with the aggressiveness of human oral squamous cell carcinoma. Arch Oral Biol 60, 1416-1427. doi:10.1016\/j.archoralbio.2015.06.007","DOI":"10.1016\/j.archoralbio.2015.06.007"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Morales-Gonz\u00e1lez S, Calaf GM, Acu\u00f1a M, Tapia JC, Jara L (2025) The miR-146a single nucleotide polymorphism rs2910164 promotes proliferation, chemoresistance, migration, invasion, and apoptosis suppression in breast cancer cells. Cells 14, 612. doi:10.3390\/cells14080612","DOI":"10.3390\/cells14080612"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Narasimhan S, Narasimhan M, Shetty SR, Rajan ST, Al Kawas S, Subramani VN (2023) Analyzing the expression of microRNA-375 and its target gene p53 in oral squamous cell carcinoma and its implication in oral carcinogenesis. Biomed Pharmacol J 16, 2051-2060. doi:10.13005\/bpj\/2781","DOI":"10.13005\/bpj\/2781"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Zhang B, Li Y, Hou D, Shi Q, Yang S, Li Q (2017) MicroRNA-375 inhibits growth and enhances radiosensitivity in oral squamous cell carcinoma by targeting insulin-like growth factor 1 receptor. Cell Physiol Biochem 42, 2105-2117. doi:10.1159\/000479913","DOI":"10.1159\/000479913"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Avissar M, Christensen BC, Kelsey KT, Marsit CJ (2009) MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 15, 2850-2855. doi:10.1158\/1078-0432.CCR-08-3131","DOI":"10.1158\/1078-0432.CCR-08-3131"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Liu KYP, Zhu SY, Brooks D, Bowlby R, Durham JS, Ma Y et al. (2020) Tumor microRNA profile and prognostic value for lymph node metastasis in oral squamous cell carcinoma patients. Oncotarget 11, 2204-2214. doi:10.18632\/oncotarget.27616","DOI":"10.18632\/oncotarget.27616"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Harris T, Jimenez L, Kawachi N, Fan JB, Chen J, Belbin T et al. (2012) Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. Am J Pathol 180, 917-928. doi:10.1016\/j.ajpath.2011.12.004","DOI":"10.1016\/j.ajpath.2011.12.004"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Lu Z, He Q, Liang J, Li W, Su Q, Chen Z et al. (2019) miR-31-5p is a potential circulating biomarker and therapeutic target for oral cancer. Mol Ther Nucleic Acids 16, 471-480. doi:10.1016\/j.omtn.2019.03.012","DOI":"10.1016\/j.omtn.2019.03.012"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Mahmood N, Hanif M, Ahmed A, Jamal Q, Mushtaq S, Khan A et al. (2019) Circulating miR-21 as a prognostic and predictive biomarker in oral squamous cell carcinoma. Pak J Med Sci 35, 1408-1413. doi:10.12669\/pjms.35.5.331","DOI":"10.12669\/pjms.35.5.331"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Jadhav KB, Shah V, Mahajan A, Malhotra P, Parmar G, Shah J (2022) Salivary and tumour tissue miR-21 for prediction of cervical lymph node metastasis in patients with oral squamous cell carcinoma: an observational study. Lancet Oncol 23, S26. doi:10.1016\/S1470-2045(22)00425-9","DOI":"10.1016\/S1470-2045(22)00425-9"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Mahmood N, Jamal Q, Al-Kahtani R, Mushtaq S, Akhlaq H, Aamir S (2023) Deciphering the link between chewing habits and microRNA-21 dysregulation in oral squamous cell carcinoma: a potential cancerous blend. Biomed Pharmacol J 16, 389-398. doi:10.13005\/bpj\/2620","DOI":"10.13005\/bpj\/2620"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Sun Y, Li L, Hao W (2021) Post-chemotherapy miR-146a expression and its prognostic potential in oral cancer patients. Trop J Pharm Res 20, 2205-2211. doi:10.4314\/tjpr.v20i10.27","DOI":"10.4314\/tjpr.v20i10.27"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Polz A, Morshed K, Bibik R, Drop B, Drop A, Polz-Dacewicz M (2023) Serum and saliva level of miR-31-5p and miR-let-7a in EBV-associated oropharyngeal cancer. Int J Mol Sci 24, 11965. doi:10.3390\/ijms241511965","DOI":"10.3390\/ijms241511965"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. Al-Rawi NH, Rizvi Z, Mkadmi S, Kou RA, Elmabrouk N, Alrashdan MS et al. (2023) Differential expression profile of salivary oncomiRNAs among smokeless tobacco users. Eur J Dent 17, 1215-1220. doi:10.1055\/s-0043-1761191","DOI":"10.1055\/s-0043-1761191"}],"container-title":["Journal of Oral Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/josnusd\/68\/2\/68_25-0294\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:24:44Z","timestamp":1776486284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/josnusd\/68\/2\/68_25-0294\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2334\/josnusd.25-0294","relation":{},"ISSN":["1343-4934","1880-4926"],"issn-type":[{"value":"1343-4934","type":"print"},{"value":"1880-4926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"25-0294"}}